The impact of substance abuse treatment modality on birth weight and health care expenditures

Journal of Psychoactive Drugs
M DaleyC N Williams

Abstract

During the 1990s, substance abuse treatment programs were developed for pregnant women to help improve infant birth outcomes, reduce maternal drug dependency and promote positive lifestyle changes. This study compared the relative impact of five treatment modalities--residential, outpatient, residential/outpatient, methadone and detoxification-only--on infant birth weight and perinatal health care expenditures for a sample of 445 Medicaid-eligible pregnant women who received treatment in Massachusetts between 1992 and 1997. Costs and outcomes were measured using the Addiction Severity Index and data from birth certificates, substance abuse treatment records and Medicaid claims. Multiple regression was used to control for intake differences between the groups. Results showed a near linear relationship between birth weight and amount of treatment received. Women who received the most treatment (the residential/outpatient group) delivered infants who were 190 grams heavier than those who received the least treatment (the detoxification-only group) for an additional cost of $17,211. Outpatient programs were the most cost-effective option, increasing birth weight by 139 grams over detoxification-only for an investment of only $1,788...Continue Reading

References

Jan 1, 1992·Journal of Substance Abuse Treatment·A T McLellanM Argeriou
Mar 24, 1989·JAMA : the Journal of the American Medical Association·I J ChasnoffK A Burns
Dec 1, 1993·American Journal of Public Health
Aug 1, 1995·American Journal of Public Health·P H HughesJ C Anthony
Jan 1, 1995·American Journal of Public Health·K FoxJ A Califano
Oct 1, 1994·American Journal of Public Health·V BreitbartP H Wise
Nov 1, 1993·The International Journal of the Addictions·N Finkelstein
Aug 1, 1993·The Journal of Nervous and Mental Disease·D L HallerS H Schnoll
May 1, 1996·The American Journal of Drug and Alcohol Abuse·S EgelkoK Marinelli
Oct 1, 1995·Journal of Psychoactive Drugs·I H Strantz, S P Welch
May 1, 1996·Journal of Substance Abuse Treatment·C ZlotnickM St John
Apr 14, 1997·Drug and Alcohol Dependence·D S SvikisC E Ball
Jul 1, 1997·Journal of Substance Abuse Treatment·M P LakenJ Ager
Jul 1, 1997·Journal of Substance Abuse Treatment·K BellJ Anastas
Jan 23, 1998·Journal of Substance Abuse Treatment·J M Camp, N Finkelstein
Jan 23, 1998·Journal of Substance Abuse Treatment·D L HallerS H Schnoll
Aug 5, 1996·Evaluation & the Health Professions·A MarshR B Straw

❮ Previous
Next ❯

Citations

Aug 28, 2003·The Milbank Quarterly·Peter D JacobsonC Christine Fair
Dec 18, 2012·Neuropsychiatry·Verena MetzGabriele Fischer
Aug 7, 2009·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Ana de CastroMarilyn A Huestis
May 19, 2009·Women's Health Issues : Official Publication of the Jacobs Institute of Women's Health·Benita J Walton-MossErika Kiefer
Jun 29, 2007·Journal of Substance Abuse Treatment·William S Cartwright
Nov 20, 2012·Human Psychopharmacology·Bernadette Winklbaur-HausknostGabriele Fischer
Jun 30, 2004·Journal of Substance Abuse Treatment·Wendy B KissinMaxine L Stitzer
Apr 3, 2008·Current Opinion in Psychiatry·Bernadette WinklbaurGabriele Fischer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.